Year
2017
Status
Active
Team
Field
Hematology therapeutic
Location
Leiden (Netherlands)
Fund
BGV III
VarmX
VarmX develops a modified factor Xa as a reversal agent for anti-coagulants.
2017
Active
Hematology therapeutic
Leiden (Netherlands)
BGV III
VarmX develops a modified factor Xa as a reversal agent for anti-coagulants.